Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Emanuel Barbiera Romero"'
Autor:
Renata Curciarello, Karina E. Canziani, Ileana Salto, Emanuel Barbiera Romero, Andrés Rocca, Ivan Doldan, Emmanuel Peton, Santiago Brayer, Alicia M. Sambuelli, Silvina Goncalves, Pablo Tirado, Gustavo J. Correa, Martín Yantorno, Laura Garbi, Guillermo H. Docena, María de los Ángeles Serradell, Cecilia I. Muglia
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Ulcerative colitis and Crohn’s disease, the two main forms of inflammatory bowel disease (IBD), are immunologically mediated disorders. Several therapies are focused on activated T cells as key targets. Although Lactobacillus kefiri has shown anti-
Externí odkaz:
https://doaj.org/article/926b9e5eb0ad4b6188bc108a2f67ec44
Autor:
Silvina A. Goncalves, Gustavo Correa, Ivan Doldan, Cecilia Isabel Muglia, Renata Curciarello, Andrés Rocca, Emanuel Barbiera Romero, Guillermo Horacio Docena, Santiago Brayer, María de los Ángeles Serradell, Pablo Tirado, Alicia M. Sambuelli, Karina Eva Canziani, Emmanuel Peton, Ileana Paula Salto, Martin Yantorno, Laura Garbi
Publikováno v:
Frontiers in Pharmacology
SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
Frontiers in Pharmacology, Vol 12 (2021)
SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
Frontiers in Pharmacology, Vol 12 (2021)
Ulcerative colitis and Crohn’s disease, the two main forms of inflammatory bowel disease (IBD), are immunologically mediated disorders. Several therapies are focused on activated T cells as key targets. Although Lactobacillus kefiri has shown anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38aad3763a9e7599b6c586ce702a778
https://pubmed.ncbi.nlm.nih.gov/33935778
https://pubmed.ncbi.nlm.nih.gov/33935778